◼ Archived
Business
🔮 fades
Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles
Vertex Pharma's $10 billion purchase of Crinetics sparks a near‑doubling of its shares and a biotech‑M&A surge
Endocrine Drugs
1 trends tracked about this subject — the full history, oldest to newest below.